9 out of 10 patients with CINV report an impact on their daily life – Chugai Pharma Europe
Chugai Pharma Europe shared on LinkedIn:
“Did you know 9 out of 10 patients with chemotherapy-induced nausea and vomiting (CINV) report an impact on their daily life?
Alongside the physical and emotional burden faced by cancer patients, side effects like CINV can have a long-lasting effect on wellbeing.
Some patients may even consider stopping their chemotherapy due to CINV symptoms.
That’s why we are on a mission to deliver comprehensive cancer care, underpinned by Supportive Care.
Working with the healthcare community to provide resources and support that empower patients to manage their symptoms, and feel more in control of their wellbeing.
1. Ballatori E et al. Support Care Cancer 2007:15(2):179–85.
2. Bhandari PR. J Adv Pharm Technol Res. 2012 Oct-Dec; 3(4): 202–209.”
Source: Chugai Pharma Europe/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023